Osseointegration of dental implants can be promoted by implant-surface modifications using bisphosphonate coatings. In addition, it is of clinical interest to promote peri-implant bone formation and to restore bony structure in low bone-mass patients. The present study evaluated a combination of an anti-resorptive zoledronic acid (ZOL) implant-coating and a systemically applied sclerostin antibody, a known bone anabolic treatment principle, versus sole sclerostin antibody treatment or ZOL implant-coating in a rat osteoporosis model.
Find out more
Join Us for Our Next Thommen Talk Live Webinar Series with the AO
Topic: Precise Implant Prosthetics - The Keys to Success
Speaker: Dr. Konrad Meyenberg
Date: Thursday, December 2nd, 18:00 PM - 19:00 PM CET…